Genetically Engineered Mouse models of Brain Cancer: Preclinical Platforms for Testing Immunotherapies

Time: 4:10 pm
day: Day One


  • Description of the tools and methodologies to develop the genetically engineered immune-competent glioma mouse models
  • Phenotypic and molecular characterization of the models and generation of 3D stem cell like neurosphere cultures of the tumor cells
  •  Data related to the tumor immune microenvironment and implementation of immunotherapies, and efficacy and toxicity outcomes